These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 8420037)

  • 1. Evidence that anti-CD8 abrogates anti-CD4-mediated clonal anergy but allows allograft survival in mice.
    Song HK; Alters SE; Fathman CG
    Transplantation; 1993 Jan; 55(1):133-9. PubMed ID: 8420037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CD8 abrogates effect of anti-CD4-mediated islet allograft survival in rat model.
    Seydel K; Shizuru J; Grossman D; Wu A; Alters S; Fathman CG
    Diabetes; 1991 Nov; 40(11):1430-4. PubMed ID: 1834499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-CD4 mediates clonal anergy during transplantation tolerance induction.
    Alters SE; Shizuru JA; Ackerman J; Grossman D; Seydel KB; Fathman CG
    J Exp Med; 1991 Feb; 173(2):491-4. PubMed ID: 1899105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of skin and islet allograft survival in mice treated with costimulation blockade is mediated by different CD4+ cell subsets and different mechanisms.
    Banuelos SJ; Markees TG; Phillips NE; Appel MC; Cuthbert A; Leif J; Mordes JP; Shultz LD; Rossini AA; Greiner DL
    Transplantation; 2004 Sep; 78(5):660-7. PubMed ID: 15371665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that clonal anergy is induced in thymic migrant cells after anti-CD4-mediated transplantation tolerance.
    Alters SE; Song HK; Fathman CG
    Transplantation; 1993 Sep; 56(3):633-8. PubMed ID: 8212161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survival of hamster islet xenografts in mice under short-course treatment with nondepleting versus depleting anti-CD4 monoclonal antibodies.
    Lu X; Schulz M; Zihlmann HR; Borel JF
    Xenotransplantation; 1998 May; 5(2):154-63. PubMed ID: 9584829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for tissue-directed immune responses: analysis of CD4- and CD8-dependent alloimmunity.
    Lunsford KE; Gao D; Eiring AM; Wang Y; Frankel WL; Bumgardner GL
    Transplantation; 2004 Oct; 78(8):1125-33. PubMed ID: 15502708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anergic T cells generated in vitro suppress rejection response to islet allografts.
    Luo Z; Gotoh M; Grochowiecki T; Tanaka T; Kimura F; Kawashima H; Yagita H; Okumura K; Miyasaka M
    Transplantation; 2000 May; 69(10):2144-8. PubMed ID: 10852614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-depleting anti-CD4, but not anti-CD8, antibody induces long-term survival of xenogeneic and allogeneic hearts in alpha1,3-galactosyltransferase knockout (GT-Ko) mice.
    Chong AS; Ma L; Yin D; Shen J; Blinder L; XiuLong X; Williams JW; Byrne G; Diamond LE; Logan JS
    Xenotransplantation; 2000 Nov; 7(4):275-83. PubMed ID: 11081762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.
    Arima T; Lehmann M; Flye MW
    Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of CD8 and CD4 T cells in intestinal allograft rejection: a comparison of monoclonal antibody-treated and knockout mice.
    He G; Hart J; Kim OS; Szot GL; Siegel CT; Thistlethwaite JR; Newell KA
    Transplantation; 1999 Jan; 67(1):131-7. PubMed ID: 9921809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.
    Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF
    Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppression of canine renal allograft recipients by CD4 and CD8 monoclonal antibodies.
    Watson CJ; Cobbold SP; Davies HS; Rebello PR; Thiru S; McNair R; Rasmussen A; Waldmann H; Calne RY; Metcalfe SM
    Tissue Antigens; 1994 Mar; 43(3):155-62. PubMed ID: 7916496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
    Iwakoshi NN; Mordes JP; Markees TG; Phillips NE; Rossini AA; Greiner DL
    J Immunol; 2000 Jan; 164(1):512-21. PubMed ID: 10605049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Awareness of donor alloantigens in antiadhesion therapy induces antigen-specific unresponsiveness to islet allografts.
    Nishihara M; Gotoh M; Ohzato H; Ohta Y; Luo Z; Dono K; Umeshita K; Sakon M; Monden M; Yagita H; Okumura K; Miyasaka M
    Transplantation; 1997 Oct; 64(7):965-70. PubMed ID: 9381542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of CD4+ and CD8+ cells in islet allo- and xeno-graft rejection.
    Gotoh M; Monden M; Yamamoto H; Kawai M; Ichikawa T; Mori T; Uenaka A; Nakayama E
    Horm Metab Res Suppl; 1990; 25():173-6. PubMed ID: 1982441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism by which additional monoclonal antibody (mAB) injections overcome the requirement for thymic irradiation to achieve mixed chimerism in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
    Tomita Y; Khan A; Sykes M
    Transplantation; 1996 Feb; 61(3):477-85. PubMed ID: 8610364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-lasting unresponsiveness to polyclonal T cell-binding immunoglobulins.
    Mysliwietz J; Thierfelder S
    Eur J Immunol; 1998 Jan; 28(1):246-56. PubMed ID: 9485204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of tolerance induction after intrathymic islet injection: determination of the fate of alloreactive thymocytes.
    Turvey SE; Hara M; Morris PJ; Wood KJ
    Transplantation; 1999 Jul; 68(1):30-9. PubMed ID: 10428263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the contribution of CD4+ T cells to proislet and islet allograft rejection correlate with constitutive class II MHC alloantigen expression.
    Simeonovic CJ; Brown DJ; Townsend MJ; Wilson JD
    Cell Transplant; 1996; 5(5):525-41. PubMed ID: 8889212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.